| scholarly article | Q13442814 |
| P2093 | author name string | Monica Boirivant | |
| Manuela Colucci | |||
| Antonella D'Ambrosio | |||
| Francesca Quintieri | |||
| Orsola Pugliese | |||
| P2860 | cites work | Recombinant cholera toxin B subunit activates dendritic cells and enhances antitumor immunity. | Q40467105 |
| Bacterial-reactive T regulatory cells inhibit pathogenic immune responses to the enteric flora | Q40688436 | ||
| Cholera toxin B pretreatment of macrophages and monocytes diminishes their proinflammatory responsiveness to lipopolysaccharide | Q40753141 | ||
| Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cells. | Q41888326 | ||
| Cholera toxin subunit B inhibits IL-12 and IFN-{gamma} production and signaling in experimental colitis and Crohn's disease. | Q41998304 | ||
| Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells | Q42944333 | ||
| Oral administration of collagen conjugated with cholera toxin induces tolerance to type II collagen and suppresses chondritis in an animal model of autoimmune ear disease | Q43683297 | ||
| Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells | Q45878833 | ||
| Elevated T regulatory cells in long-term stable transplant tolerance in rhesus macaques induced by anti-CD3 immunotoxin and deoxyspergualin | Q46844016 | ||
| The cholera toxin B subunit is a mucosal adjuvant for oral tolerance induction in type 1 diabetes | Q47904800 | ||
| Induction of mucosal and systemic immune responses by intranasal immunization using recombinant cholera toxin B subunit as an adjuvant. | Q48026780 | ||
| Recombinant cholera toxin B subunit acts as an adjuvant for the mucosal and systemic responses of mice to mucosally co-administered bovine serum albumin | Q48026935 | ||
| Production of IL-10 by alloreactive sibling donor cells and its influence on the development of acute GVHD. | Q50749410 | ||
| Interleukin-10-mediated regulatory T-cell responses to epitopes on a human red blood cell autoantigen. | Q52944948 | ||
| Reduced expression of the regulatory CD4+ T cell subset is related to Th1/Th2 balance and disease severity in rheumatoid arthritis. | Q55033737 | ||
| Relation of an Interleukin-10 Promoter Polymorphism to Graft-versus-Host Disease and Survival after Hematopoietic-Cell Transplantation | Q58814550 | ||
| The induction of tolerance by dendritic cells that have captured apoptotic cells | Q24671078 | ||
| Dendritic cells and the control of immunity | Q27860918 | ||
| Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha | Q28251443 | ||
| Human CD4+ T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific Th1 immune responses | Q28369396 | ||
| Immunobiology of dendritic cells | Q29547465 | ||
| A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis | Q29619339 | ||
| A role for IL-10-mediated HLA-DR7-restricted T cell-dependent events in development of the modified Th2 response to cat allergen | Q30433007 | ||
| Oral administration of recombinant cholera toxin subunit B inhibits IL-12-mediated murine experimental (trinitrobenzene sulfonic acid) colitis | Q32024894 | ||
| Dendritic cells as key targets for immunomodulation by Vitamin D receptor ligands | Q33204344 | ||
| IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells | Q34318928 | ||
| Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. | Q34569888 | ||
| Functional modulation of dendritic cells to suppress adaptive immune responses | Q35093120 | ||
| Human allograft acceptance is associated with immune regulation | Q35128097 | ||
| IL-10-producing T cells suppress immune responses in anergic tuberculosis patients | Q35159232 | ||
| Dendritic-cell control of pathogen-driven T-cell polarization | Q35597117 | ||
| Effects of cholera toxin on innate and adaptive immunity and its application as an immunomodulatory agent | Q35619878 | ||
| IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage | Q35951526 | ||
| Different faces of regulatory DCs in homeostasis and immunity | Q36061016 | ||
| A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes | Q36140954 | ||
| In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. | Q36370315 | ||
| Tr1 cells: from discovery to their clinical application. | Q36390028 | ||
| Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit | Q37494112 | ||
| Cholera toxin B subunit as a carrier molecule promotes antigen presentation and increases CD40 and CD86 expression on antigen-presenting cells | Q39522002 | ||
| Cholera toxin and its B subunit promote dendritic cell vaccination with different influences on Th1 and Th2 development | Q39741614 | ||
| Gliadin-specific type 1 regulatory T cells from the intestinal mucosa of treated celiac patients inhibit pathogenic T cells | Q40236078 | ||
| P433 | issue | 3 | |
| P921 | main subject | dendritic cell | Q506253 |
| cholera | Q12090 | ||
| P304 | page(s) | 661-668 | |
| P577 | publication date | 2008-06-18 | |
| P1433 | published in | Journal of Leukocyte Biology | Q1524048 |
| P1476 | title | Cholera toxin B subunit promotes the induction of regulatory T cells by preventing human dendritic cell maturation | |
| P478 | volume | 84 |
| Q35155875 | AB toxins: a paradigm switch from deadly to desirable |
| Q26782576 | Cholera Toxin Subunit B as Adjuvant--An Accelerator in Protective Immunity and a Break in Autoimmunity |
| Q36551840 | Cholera toxin B subunit linked to glutamic acid decarboxylase suppresses dendritic cell maturation and function. |
| Q37954306 | Cholera-like enterotoxins and Regulatory T cells |
| Q37530535 | DNA and protein co-administration induces tolerogenic dendritic cells through DC-SIGN mediated negative signals |
| Q33820591 | Enhanced antigen uptake by dendritic cells induced by the B pentamer of the type II heat-labile enterotoxin LT-IIa requires engagement of TLR2. |
| Q34631825 | How tolerogenic dendritic cells induce regulatory T cells |
| Q84401327 | Prolonged survival time of allografts by the oral administration of RDP58 linked to the cholera toxin B subunit |
| Q34629092 | Suppression of dendritic cell activation by diabetes autoantigens linked to the cholera toxin B subunit. |
| Q27687098 | Targeting dendritic cell function during systemic autoimmunity to restore tolerance |
| Q57490842 | The Nontoxic Cholera B Subunit Is a Potent Adjuvant for Intradermal DC-Targeted Vaccination |
| Q26785900 | The Role of Indoleamine 2, 3-Dioxygenase in Immune Suppression and Autoimmunity |
| Q34422017 | The role of dendritic cells in tissue-specific autoimmunity. |
| Q47105986 | Therapeutic Potential of Cholera Toxin B Subunit for the Treatment of Inflammatory Diseases of the Mucosa |
| Q35138715 | Vibrio cholerae O1 infection induces proinflammatory CD4+ T-cell responses in blood and intestinal mucosa of infected humans |
Search more.